Analyst consensus rating
Annovis Bio Analyst Rating: Strong Buy
ANVS is rated Strong Buy by 3 analysts with a $11.00 target. As of 2026-08-24.
Direct answer
Annovis Bio's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $11.00.
Forecast evidence checked August 24, 2026.
Get free Annovis Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.75
- Average price target
- $11.00
- High price target
- $17.00
- Low price target
- $8.00
- Low target gap
- +357.1%
- Target upside
- +528.6%
- High target gap
- +871.4%
- Target range width
- 514.3%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- August 24, 2026
- Valid through
- August 31, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Annovis Bio?
Annovis Bio has a verified Strong Buy consensus. The same dataset has an average price target of $11.00.
How far are Annovis Bio's low and high targets from the recorded price?
The low target implies +357.1%, while the high target implies +871.4%.
How many analysts are included in Annovis Bio's consensus?
The verified consensus includes 3 analysts.
How is Annovis Bio's target upside or downside calculated?
The average target of $11.00 is divided by the recorded price of $1.75, then one is subtracted to produce +528.6%. This does not guarantee a future return.
When was Annovis Bio's analyst forecast verified?
The data was verified on 2026-08-24. The dataset is valid through 2026-08-31.